Intuitive Surgical Gets FDA OK for Latest Robotic System
By Ben Glickman
Intuitive Surgical said Thursday it received approval from U.S. regulators for its latest robotic system for surgery, the da Vinci 5.
The Sunnyvale, Calif.-based company said the U.S. Food and Drug Administration cleared its 510(k) form, allowing Intuitive to bring its product to market.
The company's new multiport robotic system will first be available to a small number of customers in the U.S. who worked with the company during development. Intuitive said it would generate additional data on the system before a wider commercial rollout.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
March 14, 2024 17:02 ET (21:02 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing